These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32068901)

  • 1. Enhancing global access to cancer medicines.
    Cortes J; Perez-García JM; Llombart-Cussac A; Curigliano G; El Saghir NS; Cardoso F; Barrios CH; Wagle S; Roman J; Harbeck N; Eniu A; Kaufman PA; Tabernero J; García-Estévez L; Schmid P; Arribas J
    CA Cancer J Clin; 2020 Mar; 70(2):105-124. PubMed ID: 32068901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to essential medicines to treat chronic respiratory disease in low-income countries.
    Bissell K; Perrin C; Beran D
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to medicines through health systems in low- and middle-income countries.
    Ozawa S; Shankar R; Leopold C; Orubu S
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii1-iii3. PubMed ID: 31816069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
    Baxi SM; Beall R; Yang J; Mackey TK
    Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supply chain management of health commodities for reducing global disease burden.
    Chukwu OA; Ezeanochikwa VN; Eya BE
    Res Social Adm Pharm; 2017; 13(4):871-874. PubMed ID: 27720436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
    Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?
    Assefa Y; Hill PS; Ulikpan A; Williams OD
    Global Health; 2017 Sep; 13(1):73. PubMed ID: 28903757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering affordable cancer care in high-income countries.
    Sullivan R; Peppercorn J; Sikora K; Zalcberg J; Meropol NJ; Amir E; Khayat D; Boyle P; Autier P; Tannock IF; Fojo T; Siderov J; Williamson S; Camporesi S; McVie JG; Purushotham AD; Naredi P; Eggermont A; Brennan MF; Steinberg ML; De Ridder M; McCloskey SA; Verellen D; Roberts T; Storme G; Hicks RJ; Ell PJ; Hirsch BR; Carbone DP; Schulman KA; Catchpole P; Taylor D; Geissler J; Brinker NG; Meltzer D; Kerr D; Aapro M
    Lancet Oncol; 2011 Sep; 12(10):933-80. PubMed ID: 21958503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis.
    Sruamsiri R; Wagner AK; Ross-Degnan D; Lu CY; Dhippayom T; Ngorsuraches S; Chaiyakunapruk N
    BMJ Open; 2016 Mar; 6(3):e008671. PubMed ID: 26988346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving quality through cost recovery in Niger.
    Wouters A
    Health Policy Plan; 1995 Sep; 10(3):257-70. PubMed ID: 10151843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making the Best Use of Resources in Global Cancer Care.
    Gago J; Pendharkar D; Tripathi C; Ginsburg O
    Am Soc Clin Oncol Educ Book; 2020 May; 40():e361-e366. PubMed ID: 32614655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.
    Vogler S; Paris V; Ferrario A; Wirtz VJ; de Joncheere K; Schneider P; Pedersen HB; Dedet G; Babar ZU
    Appl Health Econ Health Policy; 2017 Jun; 15(3):307-321. PubMed ID: 28063134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
    Guan X; Hu H; Man C; Shi L
    Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
    Zhu Y; Wang Y; Sun X; Li X
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of Essential Medicines for Pediatric Oncology in Armenia.
    Simonyan T; Papyan R; Danielyan S; Sargsyan L; Grigoryan V; Topchyan H; Azaryan A; Tananyan A; Muradyan A; Tamamyan G
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):991-994. PubMed ID: 31030465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to essential medicines for sexual and reproductive health care: the role of the pharmaceutical industry and international regulation.
    Cottingham J; Berer M
    Reprod Health Matters; 2011 Nov; 19(38):69-84. PubMed ID: 22118143
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.